Relay Therapeutics Insider Sale Sparks Stock Rally
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
This intro examines risk profiles for index vs target date funds, offering a clear take on volatility, diversification, and potential drawdowns.
24,893 articlesA large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
Bitget introduces US stock options and tokenized stocks, a move that fuels debate over ownership on crypto platforms....
AscendEX has suspended all operations as of July 1, 2026, warning users that full balance recovery cannot be guarante...
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A shadowy hosting network in Russia reportedly kept cybercrime online, driving millions in losses. This guide explain...
A cross-party group of UK lawmakers is probing how banks treat crypto businesses. The inquiry aims to uncover barrier...
A New York-based issuer sells rated notes backed by a pool of bitcoin-backed consumer loans, signaling a milestone fo...
Playnance reports Be The Boss has delivered over $2 million in real payouts and grown to 2,809 active Bosses, as it p...
As markets navigate a choppy start to March 2026, traders rely on the best stock scanners screeners to turn vast data...
Oracle is reshaping its business from database software to a cloud infrastructure powerhouse, fueled by surging backl...
When a CEO disposes of stock, investors want context. This deep dive explains what fastly's sold company shares could...
A relative says six figures are missing after an aunt’s attorney seized control of her finances, aided by doctors who...